Purposing Saikosaponins for the treatment of COVID-19.
作者信息
Bahbah Eshak I, Negida Ahmed, Nabet Mohamed Salah
机构信息
School of Medicine, Al-Azhar University, Damietta, Egypt.
School of Pharmacy and Biological Sciences, University of Portsmouth, UK.
出版信息
Med Hypotheses. 2020 Jul;140:109782. doi: 10.1016/j.mehy.2020.109782. Epub 2020 Apr 23.
Abstract
摘要
相似文献
1
Purposing Saikosaponins for the treatment of COVID-19.
Med Hypotheses. 2020 Jul;140:109782. doi: 10.1016/j.mehy.2020.109782. Epub 2020 Apr 23.
2
Analysis of the molecular mechanism of Pudilan (PDL) treatment for COVID-19 by network pharmacology tools.
Biomed Pharmacother. 2020 Aug;128:110316. doi: 10.1016/j.biopha.2020.110316. Epub 2020 May 30.
3
Drugs and the renin-angiotensin system in covid-19.
BMJ. 2020 Apr 2;369:m1313. doi: 10.1136/bmj.m1313.
4
The association between obesity and poor outcome after COVID-19 indicates a potential therapeutic role for montelukast.
Med Hypotheses. 2020 Oct;143:109883. doi: 10.1016/j.mehy.2020.109883. Epub 2020 May 27.
5
Dapsone and doxycycline could be potential treatment modalities for COVID-19.
Med Hypotheses. 2020 Jul;140:109768. doi: 10.1016/j.mehy.2020.109768. Epub 2020 Apr 22.
6
Scaffold morphing of arbidol (umifenovir) in search of multi-targeting therapy halting the interaction of SARS-CoV-2 with ACE2 and other proteases involved in COVID-19.
Virus Res. 2020 Nov;289:198146. doi: 10.1016/j.virusres.2020.198146. Epub 2020 Aug 29.
7
A pharmacological perspective of chloroquine in SARS-CoV-2 infection: An old drug for the fight against a new coronavirus?
Int J Antimicrob Agents. 2020 Sep;56(3):106078. doi: 10.1016/j.ijantimicag.2020.106078. Epub 2020 Jul 4.
8
Sitagliptin Repositioning in SARS-CoV-2: Effects on ACE-2, CD-26, and Inflammatory Cytokine Storms in the Lung.
Iran J Allergy Asthma Immunol. 2020 May 17;19(S1):10-12. doi: 10.18502/ijaai.v19i(s1.r1).2849.
9
Proposed use of thalidomide for the cytokine storm of COVID-19.
Clin Dermatol. 2020 Jul-Aug;38(4):508. doi: 10.1016/j.clindermatol.2020.04.015. Epub 2020 Apr 28.
10
Déjà vu: Stimulating open drug discovery for SARS-CoV-2.
Drug Discov Today. 2020 May;25(5):928-941. doi: 10.1016/j.drudis.2020.03.019. Epub 2020 Apr 19.
引用本文的文献
1
Secondary metabolites of Alternaria alternate appraisal of their SARS-CoV-2 inhibitory and anti-inflammatory potentials.
PLoS One. 2025 Jan 24;20(1):e0313616. doi: 10.1371/journal.pone.0313616. eCollection 2025.
2
The Application of Biomaterials for the Vaccine, Treatment, and Detection of SARS-CoV-2.
ACS Omega. 2024 Jan 26;9(5):5175-5192. doi: 10.1021/acsomega.3c08326. eCollection 2024 Feb 6.
3
Bioactive metabolites identified from Aspergillus terreus derived from soil.
AMB Express. 2023 Oct 3;13(1):107. doi: 10.1186/s13568-023-01612-0.
4
Potential herb‒drug interactions between anti-COVID-19 drugs and traditional Chinese medicine.
Acta Pharm Sin B. 2023 Jun 5;13(9):3598-637. doi: 10.1016/j.apsb.2023.06.001.
5
Saponins: Research Progress and Their Potential Role in the Post-COVID-19 Pandemic Era.
Pharmaceutics. 2023 Jan 20;15(2):348. doi: 10.3390/pharmaceutics15020348.
6
Plant Extracts and SARS-CoV-2: Research and Applications.
Life (Basel). 2023 Jan 31;13(2):386. doi: 10.3390/life13020386.
7
A global picture: therapeutic perspectives for COVID-19.
Immunotherapy. 2022 Apr;14(5):351-371. doi: 10.2217/imt-2021-0168. Epub 2022 Feb 21.
8
Outcomes of tocilizumab therapy in severe or critical COVID-19 patients: A retrospective cohort, single-centre study.
Trop Med Int Health. 2021 Dec;26(12):1689-1699. doi: 10.1111/tmi.13685. Epub 2021 Oct 19.
9
Pathomechanisms, therapeutic targets and potent inhibitors of some beta-coronaviruses from bench-to-bedside.
Infect Genet Evol. 2021 Sep;93:104944. doi: 10.1016/j.meegid.2021.104944. Epub 2021 May 28.
10
COVID-19 and pulmonary fibrosis: therapeutics in clinical trials, repurposing, and potential development.
Arch Pharm Res. 2021 May;44(5):499-513. doi: 10.1007/s12272-021-01331-9. Epub 2021 May 28.
本文引用的文献
1
Antiviral and Immunoregulatory Role Against PCV2 of Chinese Herbal Medicinal Ingredients.
J Vet Res. 2017 Dec 27;61(4):405-410. doi: 10.1515/jvetres-2017-0062. eCollection 2017 Dec.
2
A systematic review of the active saikosaponins and extracts isolated from Radix Bupleuri and their applications.
Pharm Biol. 2017 Dec;55(1):620-635. doi: 10.1080/13880209.2016.1262433.
3
Antiviral effects of saikosaponins on human coronavirus 229E in vitro.
Clin Exp Pharmacol Physiol. 2006 Jul;33(7):612-6. doi: 10.1111/j.1440-1681.2006.04415.x.
Zotero 插件